Fidelity Advisor Biotechnology Fund

Scorecard
4 / 5 Stars
Lipper
5 4 4 1 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A (Buy)

Fund Performance

Hypothetical Growth of $10,000

Updated 04.30.2013

Trailing Total Returns

Updated 04.30.2013

Total Return % + / - MSCI World NR USD + / - DJ US Health Care TR USD % Rank
Year-to-date 26.61 15.49 6.76 10
1-Month 5.76 2.61 2.47 11
3-Month 18.24 12.50 6.80 5
6-Month 30.71 16.05 10.17 9
1-Year 43.74 27.04 13.50 6
3-Year (Annualized) 26.42 16.83 8.21 5
5-Year (Annualized) 18.05 16.23 6.38 11
10-Year (Annualized) 12.64 4.35 3.79 24
Advertisement
Healths
Rankings

See More Funds

Highest Returns (10-year)

See More Funds

Slide Shows
7 Mutual Funds That Make Huge Bets

These funds invest much of their portfolios in one company.

Why Dow 14,000 Is a Tough Milestone

History shows this mark to be one of the most difficult for the market.

Emerging Markets to Consider in 2013

The Philippines, China and other key emerging markets for this year.